Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2023 | 3 |
2024 | 3 |
Search Results
6 results
Results by year
Filters applied: . Clear all
Page 1
SARS-CoV-2 Fusion Peptide Conjugated to a Tetravalent Dendrimer Selectively Inhibits Viral Infection.
Pharmaceutics. 2023 Dec 17;15(12):2791. doi: 10.3390/pharmaceutics15122791.
Pharmaceutics. 2023.
PMID: 38140131
Free PMC article.
Outcome of COVID-19 patients with haematological malignancies after the introduction of vaccination and monoclonal antibodies: results from the HM-COV 2.0 study.
Oliva A, Cogliati Dezza F, Petrucci F, Romani FE, Morviducci M, Mirabelli FM, Cancelli F, Valeriani E, Marcelli G, Pugliese F, Turriziani O, Ricci P, Venditti M, Palange P, Mastroianni CM.
Oliva A, et al.
Clin Exp Med. 2023 Oct;23(6):2275-2285. doi: 10.1007/s10238-023-01027-y. Epub 2023 Mar 3.
Clin Exp Med. 2023.
PMID: 36867292
Free PMC article.
Item in Clipboard
Fast and Sensitive Method for Simultaneous Quantification of Meropenem and Vaborbactam in Human Plasma Microsamples by Liquid Chromatography-Tandem Mass Spectrometry for Therapeutic Drug Monitoring.
Barone R, Conti M, Giorgi B, Gatti M, Cojutti PG, Viale P, Pea F.
Barone R, et al.
Antibiotics (Basel). 2023 Apr 6;12(4):719. doi: 10.3390/antibiotics12040719.
Antibiotics (Basel). 2023.
PMID: 37107082
Free PMC article.
Meropenem (MRP)-Vaborbactam (VBR) is a novel beta-lactam/beta-lactamase inhibitor used for the management of difficult-to-treat Gram-negative infections. Among critically ill patients, MRP-VBR shows remarkable inter-individual variability in pharmacokinetic behavior, thus …
Meropenem (MRP)-Vaborbactam (VBR) is a novel beta-lactam/beta-lactamase inhibitor used for the management of difficult-to-treat Gram- …
Item in Clipboard
An Overview of Frog Skin-Derived Esc Peptides: Promising Multifunctional Weapons against Pseudomonas aeruginosa-Induced Pulmonary and Ocular Surface Infections.
Mangoni ML, Loffredo MR, Casciaro B, Ferrera L, Cappiello F.
Mangoni ML, et al.
Int J Mol Sci. 2024 Apr 16;25(8):4400. doi: 10.3390/ijms25084400.
Int J Mol Sci. 2024.
PMID: 38673985
Free PMC article.
Review.
Item in Clipboard
The Long-Term Immunogenicity of mRNABNT162b Third Vaccine Dose in Solid Organ Transplant Recipients.
Zingaropoli MA, Guardiani M, Dominelli F, Tortellini E, Garofalo M, Cogliati Dezza F, Centofanti A, Carillo C, Napoli A, Venuta F, Mastroianni CM, Pretagostini R, Lichtner M, Ciardi MR, Russo G.
Zingaropoli MA, et al.
Vaccines (Basel). 2024 Feb 22;12(3):224. doi: 10.3390/vaccines12030224.
Vaccines (Basel). 2024.
PMID: 38543858
Free PMC article.
Item in Clipboard
Anopheles sacharovi in Italy: first record of the historical malaria vector after over 50 years.
Raele DA, Severini F, Toma L, Menegon M, Boccolini D, Tortorella G, Di Luca M, Cafiero MA.
Raele DA, et al.
Parasit Vectors. 2024 Apr 10;17(1):182. doi: 10.1186/s13071-024-06252-2.
Parasit Vectors. 2024.
PMID: 38600589
Free PMC article.
Item in Clipboard
Cite
Cite